The DASH diet enhances the blood pressure response to losartan in hypertensive patients

American Journal of Hypertension

Volumn 16, Issue 5 I, 2003, Pages 337-342

  Conlin, Paul R ^a,b   Erlinger, Thomas P ^c   Bohannon, Arline ^d   Miller III, Edgar R ^c   Appel, Lawrence J ^c   Svetkey, Laura P ^d   Moore, Thomas J ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood pressure; DASH diet; Hypertension; Losartan

Indexed keywords

LOSARTAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CALCIUM INTAKE; CARBOHYDRATE INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DIETARY FIBER; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; ESSENTIAL HYPERTENSION; ETHNIC DIFFERENCE; FEMALE; FOOD INTAKE; FRUIT; HORMONE ACTION; HUMAN; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POTASSIUM INTAKE; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VEGETABLE;

EID: 0038742050     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00056-6     Document Type: Article

References (26)

1. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-1124.
2. Conlin PR, Chow D, Miller ER III, Svetkey LP, Lin PH, Harsha DW, Moore TJ, Sacks FM, Appel LJ, for the DASH Research Group: The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Hypertens 2000;13:949-955.
3. Moore TM, Conlin PR, Ard J, Svetkey LP: The DASH diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension 2001;38:155-158.
4. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure. Arch Intern Med 1997;157:2413-2445.
5. Svetkey LP, Moore TJ, Simons-Morton DG, Appel LJ, Bray GA, Sacks FM, Ard JD, Mortensen RM, Mitchell SR, Conlin PR, Kesari M: Angiotensinogen genotype and BP response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 2001;19:1949-1956.
6. Sacks F, Obarzanek E, Windhauser M, Svetkey LP, Vollmer WM, McCullough M, Karanja N, Lin PH, Steele P, Proschan MA, Evans MA, Appel LJ, Bray GA, Vogt TM, Moore TJ: Rationale and design of the dietary approaches to stop hypertension trial. Ann Epidemiol 1995;5:108-118.
7. Sciarrone SE, Beilin LJ, Rouse IL, Rogers PB: A factorial study of salt restriction and a low-fat/high-fibre diet in hypertensive subjects. J Hypertens 1992;10:287-298.
8. Little P, Girling G, Hasler A, Trafford A, Craven A: A controlled trial of a low sodium, low fat, high fibre diet in treated hypertensive patients: the efficacy of multiple dietary intervention. Postgrad Med J 1990;66:616-621.
9. Miller ER III, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, Appel LJ: Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT). Hypertension 2002;40:612-618.
10. Moore TJ, Vollmer WM, Appel LJ, Sacks FM, Svetkey LP, Vogt TM, Conlin PR, Simons-Morton D, Carter-Edwards L, Harsha DM: Effect of dietary patterns on ambulatory blood pressure: results from the DASH study. Hypertension 1999;34:472-477.
11. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER III, Simons-Morton DG, Karanja N, Lin P-H, for the DASH-Sodium collaborative research group: a clinical trial of the effects on blood pressure of reduced dietary sodium and the DASH dietary pattern (the DASH-Sodium trial). N Eng J Med 2001;344:3-10.
12. Weir MR, Gray JM, Paster R, Saunders E: Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group. Hypertension 1995;26:124-130.
13. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents: Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-921.
14. Middlemost SJ, Tager R, Davis J, Sareli P: Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients. Am J Cardiol 1994;73:1092-1097.
15. Dahlof B, Hansson L, Acosta JH, Bolzano K, Fairhurst G, Ferreira C, Kaarsalo E, Silva MC, Simone A: Controlled trial of enalapril and hydrochlorothiazide in 200 hypertensive patients. Am J Hypertens 1988;1:38-41.
16. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charm A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-180.
17. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH: Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997;29:1078-1082.
18. Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, Allender PS, Walker WG, Whelton PK, Williams RR: Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension 1998;32:393-401.
19. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JE, Brown MJ: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995;13:1602-1609.
20. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D, Ward R: Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997;95:2348-2350.
21. Hollenberg NK, Williams GH, Burger B: The influence of potassium on the renal vasculature and the adrenal gland and their responsiveness to angiotensin II in normal man. Clin Sci Mol Med 1975;49:527-534.
22. Langford HG, Cushman WC, Hsu H: Chronic effect of KC1 on black-white differences in plasma renin activity, aldosterone, and urinary electrolytes. Am J Hypertens 1991;4:399-403.
23. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-1632.
24. Resnick LM, Muller FB, Laragh JH: Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986;105:649-654.
25. Petrov V, Lijnen P: Modification of intracellular calcium and plasma renin by dietary calcium in men. Am J Hypertens 1999;12:1217-1224.
26. Resnick LM, Oparil S, Chait A, Haynes RB, Kris-Etherton P, Stern JS, Clark S, Holcomb S, Hatton DC, Metz JA, McMahon M, Pi-Sunyer FX, McCarron DA: Factors affecting blood pressure responses to diet: the Vanguard study. Am J Hypertens 2000;13:956-965.